I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Heidi Fields Biography and Net Worth

Director of Agilent Technologies

Ms. Heidi K. Fields is Independent Director of Agilent Technologies, Inc. Ms. Fields served as Executive Vice President and Chief Financial Officer of Blue Shield of California from September 2003 through December 2012. She served as Executive Vice President and the Chief Financial Officer of Gap, Inc. from 1999 to January 2003. Prior to assuming that position, Ms. Fields served as the Chief Financial Officer of ITT Industries, Inc. from 1995 to 1999. From 1979 to 1995, she held senior financial management positions at General Motors Corporationrationration, including Vice President and Treasurer. Ms. Fields possesses significant experience and experience in management and financial matters, having served as the Chief Financial Officer of both public and private companies, including at Blue Shield of California, Gap, Inc. and ITT Industries, Inc

What is Heidi Fields' net worth?: The estimated net worth of Heidi Fields is at least $7.07 million as of March 5th, 2024. Ms. Fields owns 54,976 shares of Agilent Technologies stock worth more than $7,068,264 as of November 21st. This net worth evaluation does not reflect any other investments that Ms. Fields may own. Learn More about Heidi Fields' net worth.
How do I contact Heidi Fields?: The corporate mailing address for Ms. Fields and other Agilent Technologies executives is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. Agilent Technologies can also be reached via phone at (800) 227-9770 and via email at [email protected]. Learn More on Heidi Fields' contact information.
Has Heidi Fields been buying or selling shares of Agilent Technologies?: Heidi Fields has not been actively trading shares of Agilent Technologies in the last ninety days. Most recently, Heidi Fields sold 1,658 shares of the business's stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $144.34, for a transaction totalling $239,315.72. Following the completion of the sale, the director now directly owns 54,976 shares of the company's stock, valued at $7,935,235.84. Learn More on Heidi Fields' trading history.
Who are Agilent Technologies' active insiders?: Agilent Technologies' insider roster includes Henrik Ancher-Jensen (SVP), Philip Binns (SVP), Heidi Fields (Director), Rodney Gonsalves (VP), Dominique Grau (SVP), Boon Koh (Director), Padraig Mcdonnell (VP), Michael Mcmullen (CEO), Samraat Raha (VP), Michael Tang (SVP), and Jacob Thaysen (VP). Learn More on Agilent Technologies' active insiders.
Are insiders buying or selling shares of Agilent Technologies?: In the last twelve months, insiders at the medical research company sold shares 15 times. They sold a total of 188,450 shares worth more than $26,218,301.86. The most recent insider tranaction occured on September, 27th when CEO Padraig Mcdonnell sold 47 shares worth more than $7,050.00. Learn More about insider trades at Agilent Technologies.
Information on this page was last updated on 9/27/2024.

Heidi Fields Insider Trading History at Agilent Technologies

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2024	Sell	1,658	$144.34	$239,315.72	54,976
6/4/2020	Sell	10,392	$91.00	$945,672.00	53,509
9/20/2019	Sell	4,000	$78.56	$314,240.00	53,287
8/30/2019	Sell	4,000	$70.96	$283,840.00
9/11/2018	Sell	5,482	$67.73	$371,295.86
3/27/2018	Sell	5,000	$68.09	$340,450.00	57,563
6/16/2017	Sell	8,625	$59.53	$513,446.25
9/6/2016	Sell	8,072	$46.99	$379,303.28	51,836
3/31/2016	Sell	30,000	$39.91	$1,197,300.00	57,312
9/30/2014	Sell	5,032	$57.17	$287,679.44
2/21/2014	Sell	3,464	$56.80	$196,755.20	51,620
8/28/2012	Buy	1,755	$37.21	$65,303.55

Heidi Fields Buying and Selling Activity at Agilent Technologies

Agilent Technologies Company Overview

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Today's Range

Now: $128.57

$124.89

$128.71

50 Day Range

MA: $138.06

$125.70

$148.48

2 Week Range

Now: $128.57

$121.23

$155.35

Volume

1,695,972 shs

Average Volume

1,706,543 shs

Market Capitalization

$36.94 billion

P/E Ratio

26.67

Dividend Yield

0.74%

Beta

1.07

I was wrong. Dead wrong.

From Porter & Company | Ad